Hepatitis C Virus Infection Completed Phase 3 Trials for Interferon alfa (DB05258)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0033268 (Hepatitis C Virus Infection) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00308048 | 14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response | Treatment |